Clinical Trial Update: Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing immunosuppression with everolimus (Certican) after lung transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplantation

Drugs mentioned

• Certican (everolimus)

Snippet

Sponsor: Hannover Medical School | Conditions: Lung Transplantation | Phase 3 | Status: COMPLETED